Statistics
Publications
44
Citations
6K
H-Index
25
Active since
1995
Daniel Li is an author at The Ohio State University specializing in medicine, oncology, and immunotherapy.
Publications per year
1995–2024
44
44
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Ajay K. Gopal, Brad S. Kahl, Sven de Vos et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Cameron J. Turtle, Kevin A. Hay, Laïla‐Aïcha Hanafi et al. · Journal of Clinical Oncology · 2017 · 657 citations
Medicine, Hematology, Oncology +17
1–5 of 44